Zacks Investment Research upgraded shares of Equifax Inc (EFX) from NEUTRAL to OUTPERFORM on December 21, 2012, with a target price of $65.00.
Equifax delivered decent third quarter 2012 results, surpassing the Zacks Consensus Estimate on the top and bottom lines. Fourth-quarter guidance was encouraging. However, management's focus on product innovation, broadening data assets through acquisitions and continued share gains in North America were encouraging. We believe that Equifax is well positioned to benefit from its leadership in important markets and strength in international markets. Given its strong correlation to consumer and financial markets, as well as its U.S. exposure, improvement in results will be directly proportional to the country's economic recovery. Moreover, stronger mortgage activities are expected to boost Equifax' fundamentals. We upgrade the stock from Neutral to Outperform and set a target price of $64.00.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on Equifax Inc (EFX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment